Intravitreal therapy in neovascular age-related macular degeneration-adapting to increasing demand and changing times

To report the outcomes of patients with neovascular age-related macular degeneration (nAMD) at Palmerston North Eye Clinic (PNEC) during 2020 and 2021, comparing time to treatment initiation based on nurse-injector availability and during COVID-19 restrictions. Data were recorded from a prospective...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	New Zealand medical journal 2024-09, Vol.137 (1603), p.129-137
Hauptverfasser:	Nunns, Brandon, Singh, Vidit, Ah-Chan, John
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Angiogenesis Inhibitors - administration & dosage Angiogenesis Inhibitors - therapeutic use Clinics COVID-19 COVID-19 - epidemiology Electronic health records Female Humans Intravitreal Injections Macular degeneration Macular Degeneration - drug therapy Macular Degeneration - therapy Male New Zealand Nurses Ophthalmology Pandemics Patients Ranibizumab - administration & dosage Ranibizumab - therapeutic use Restrictions SARS-CoV-2 Time-to-Treatment - statistics & numerical data Vascular endothelial growth factor Wet Macular Degeneration - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!